Contact:
Patty Kehe
Dynasil Corporation of America
Phone: (607) 272-3320, ext. 26
Email:  pkehe@dynasilcorp.com

             Dynasil Announces Third Quarter 2009 Results

WEST  BERLIN, N.J. - August 12, 2009 - Dynasil Corporation of America
(OTCBB:  DYSL.OB), announced the results of operations for its  third
quarter of fiscal year 2009 ended June 30, 2009.  Dynasil Corporation
is  a  rapidly  growing manufacturer of specialized  instruments  and
products  for  a broad range of applications markets in the  medical,
industrial,   and   homeland  security/  defense  sectors.    Dynasil
currently  derives more than half of their revenues from  government-
funded  contract  research  where the  number  of  opportunities  has
significantly increased with the economic stimulus package.

Revenues  for  the quarter ended June 30, 2009 more than  tripled  to
$8.5  million  compared to revenues of $2.7 million for  the  quarter
ended  June  30,  2008.  Income from Operations for the  quarter  was
$695,191,  nearly seven times greater than $105,774 for  the  quarter
ended  June  30, 2008.  Net income for the quarter was  $393,368,  or
$0.02  per  share, compared with net income of $53,002, or $0.01  per
share,  for  the  quarter ended June 30, 2008.  For the  nine  months
ended  June 30, 2009, revenues tripled to $25.9 million, Income  from
Operations  more than tripled to $2.1 million and Net  Income  nearly
tripled  to $1,153,141 as compared to the nine months ended June  30,
2008.   This is the fourth quarter since the acquisition of Radiation
Monitoring  Devices, Inc. and certain assets of RMD Instruments,  LLC
(together, "RMD") on July 1, 2008, which was the key driver  for  the
large revenue and profitability increases.  Net Operating Loss carry-
forwards for federal taxes were exhausted during fiscal year 2008  so
fiscal  year  2009 net income was impacted by increased  federal  tax
provisions  as well as the higher interest costs related to  the  RMD
acquisition.

"With  the current situation in our economy, we are pleased  that  we
were  able  to  triple revenues and increase Income  from  Operations
seven fold for the quarter," said Craig T. Dunham, President and CEO.
"The   acquisition  of  RMD  has  significantly  increased  Dynasil's
technical capabilities and intellectual property. During the quarter,
we  hired Mr. Paul Tyra as Vice President- Commercialization to drive
the  commercialization of technology developed through our government
funded  research.  Mr. Tyra brings extensive marketing and  technical
experience  with  commercialization as well as a master's  degree  in
Engineering and an MBA from MIT.  We also have organized an  advisory
board  of  entrepreneurs  to  help accelerate  our  commercialization
efforts and to maximize its effectiveness. We continue to execute our
strategy of significant and profitable growth through organic growth,
commercialization of our broad research portfolio and acquisitions."

About   Dynasil:  Dynasil  is  a  rapidly  growing  manufacturer   of
specialized   instruments  and  products  for  a   broad   range   of
applications  markets  in  the  medical,  industrial,  and   homeland
security/  defense  sectors as well as currently deriving  more  than
half of its revenues from government-funded contract research.    Its
wholly  owned  subsidiaries are located in New Jersey, New  York  and
Massachusetts.

This  news  release  may contain forward-looking  statements  usually
containing the words "believe," "expect," "plan", "target",  "intend"
or  similar expressions.  These statements are made pursuant  to  the
safe  harbor  provisions of the Private Securities Litigation  Reform
Act.   Future  results of operations, projections, and  expectations,
which  may  relate  to  this  release,  involve  certain  risks   and
uncertainties  that could cause actual results to  differ  materially
from  the  forward-looking statements.  Factors that would  cause  or
contribute to such differences include, but are not limited  to,  the
factors detailed in the Company's Annual Report or Form 10-KSB and in
the  Company's  other  Securities and  Exchange  Commission  filings,
continuation  of  existing  market  conditions  and  demand  for  our
products.

<PAGE>

DYNASIL CORPORATION OF AMERICA AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
                              ASSETS
<TABLE>
<S>                                                  <C>           <C>
                                                        June 30,    September 30,
                                                           2009          2008
                                                        (Unaudited)
                                                        ----------    ----------
Current assets
   Cash and cash equivalents                          $  3,196,064  $ 3,882,955
   Accounts receivable, net of allowance for doubtful
     accounts of $25,870 and $70,165 and sales
     returns of $4,177 and $8,200 for June 30, 2009
     and September 30, 2008, respectively                3,813,386    3,390,703
   Inventories                                           2,503,135    2,909,730
   Deferred tax asset                                      233,500      233,500
   Prepaid expenses and other current assets               294,220      259,896
                                                        ----------   ----------
        Total current assets                            10,040,305   10,676,784
Property, Plant and Equipment, net                       2,669,597    2,694,290
Other Assets
   Intangibles, net                                      7,365,840    7,767,258
   Goodwill                                             11,054,396   11,054,396
Deferred financing costs, net                               65,615       81,136
   Other assets                                              3,091        8,360
                                                         ----------  ----------
        Total other assets                              18,488,942   18,911,150
                                                        ----------   ----------
        Total Assets                                   $31,198,844  $32,282,224
                                                        ==========   ==========
                 LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities
   Short Term Note Payable                              $      -0-   $  490,117
   Current portion of long term debt                     1,706,605    1,649,101
   Accounts payable                                        922,829    1,026,675
   Billings in excess of cost                                  -0-      216,946
   Accrued expenses and other current liabilities        1,568,354    1,440,222
                                                        ----------   ----------
        Total current liabilities                        4,197,788    4,823,061
Long-term Liabilities
   Long-term debt, net                                   6,844,976    8,178,420
   Note payable to related party                         2,000,000    2,000,000
                                                        ----------   ----------
        Total long-term liabilities                      8,844,976   10,178,420
Stockholders' Equity
   Common Stock, $.0005 par value, 40,000,000 shares
    authorized, 12,182,093 and 12,142,849 shares issued,
    11,371,933 and 11,332,689 shares outstanding             6,091        6,072
Preferred Stock, $.001 par value, 15,000,000
    Shares authorized, 5,966,000 shares                      5,966        5,966
    issued and outstanding for June 30, 2009 and
    September 31, 2008, 10% cumulative, convertible
   Additional paid in capital                           16,284,946   16,122,185
   Retained earnings                                     2,845,419    2,132,862
                                                        ----------   ----------
                                                        19,142,422   18,267,085
   Less 810,160 shares in treasury - at cost              (986,342)    (986,342)
                                                        ----------   ----------
        Total stockholders' equity                      18,156,080   17,280,743
                                                        ----------   ----------
        Total Liabilities and Stockholders' Equity     $31,198,844  $32,282,224
                                                        ==========   ==========
</TABLE>

<PAGE>

DYNASIL CORPORATION OF AMERICA AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

<TABLE>
<S>                             <C>         <C>            <C>          <C>

                                   Three Months Ended        Nine Months Ended
                                        June 30                  June 30
                                     2009        2008         2009        2008
                                  ----------   --------     --------    --------
Net sales                       $8,512,892  $2,676,263     $25,883,053  $8,537,144
Cost of sales                    4,860,590   1,972,006      15,440,128   6,097,322
                                ----------   ---------      ----------  ----------
Gross profit                     3,652,302     704,257      10,442,925   2,439,822
Selling, general and administrative
        expenses                 2,957,111     598,483       8,335,105   1,901,361
                                ----------   ---------      ----------  ----------
Income from operations             695,191     105,774       2,107,820     538,461
Interest expense, net              160,367      39,191         567,025     114,774
                                 ----------   ---------     ----------   ---------
Income before income taxes         534,824      66,583       1,540,795     423,687
Income taxes                       141,456      13,581         387,654      34,421
                                 ----------   ---------     ----------   ---------
Net income                        $393,368    $ 53,002     $1,153,141     $389,266
                                ==========   =========     ==========   ==========

Basic net income per common share   $0.02       $0.01           $0.06        $0.05
Diluted net income per common share $0.02       $0.00           $0.06        $0.05

Weighted average shares outstanding
      Basic                     11,371,933   6,743,853     11,362,745    6,559,629
      Diluted                   12,346,636   7,443,784     12,337,448    7,259,560

</TABLE>